1. Sanford Burnham Prebys Medical Discovery Institute (32 from 90 patents)

2. Sanford-Burnham Medical Research Institute (6 from 99 patents)

3. Daiichi Sankyo Company, Limited (5 from 447 patents)

4. University of Michigan (2 from 3,400 patents)

5. Wayne State University (2 from 583 patents)

6. University of Kansas (2 from 549 patents)

7. Ardea Biosciences, Inc (2 from 63 patents)

8. La Jolla Institute for Allergy and Immunology (2 from 62 patents)

9. Boundless Bio, Inc. (2 from 5 patents)

10. The United States of America, as Represented by the Secretary, Department of Health and Human Services (1 from 3,578 patents)

11. Duke University (1 from 2,020 patents)

12. Mayo Foundation for Medical Education and Research (1 from 1,756 patents)

13. Mcgill University (1 from 569 patents)

14. Selexagen Therapeutics, Inc. (1 from 1 patent)

1. 12527790 - Checkpoint kinase 1 (CHK1) inhibitors and uses thereof

2. 12319684 - Agonists of the apelin receptor and methods of use thereof

3. 12263159 - Fused ring compound having urea structure

4. 12071414 - Apelin receptor agonists and methods of use thereof

5. 12071413 - Azole derivatives as apelin receptor agonist

6. 12030896 - PIKfyve inhibitors

7. 12006321 - Substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists

8. 11932600 - Biaryl derivative

9. 11918568 - Fused ring compound having urea structure

10. 11806337 - Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof

11. 11731986 - Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof

12. 11707462 - Checkpoint kinase 1 (CHK1) inhibitors and uses thereof

13. 11673873 - Apelin receptor agonists and methods of use thereof

14. 11452717 - Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof

15. 11345705 - Substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists